Is the prognosis of heart failure improving? - Wikidata - wikimedia - TriplyDB

Is the prognosis of heart failure improving?

Is the prognosis of heart failure improving?

http://www.wikidata.org/entity/Q43735732

about

Nitrates for acute heart failure syndromes Clinical service organisation for heart failure Clinical service organisation for heart failure Nitrates for acute heart failure Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons.International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey.A systematic review of telemonitoring for the management of heart failure.Patients with treatable malignant diseases--including heart failure--are entitled to specialist care.Sequential biventricular pacing improves regional contractility, longitudinal function and dyssynchrony in patients with heart failure and prolonged QRS.Changing trends in mortality and admissions to hospital for elderly patients with congestive heart failure in Montreal Heart failure--concepts and significance. Birth of a prognostic model Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Moni Survival after initial hospitalisation for heart failure: a multilevel analysis of patients in Swedish acute care hospitals.Device based treatment of heart failure Pre-implant right ventricular function might be an important predictor of the response to cardiac resynchronization therapy.Demographics, treatment regimens and the use of angiotensin-receptor blockers in heart failure: findings from the Valsartan Heart Failure Trial.Improving patient outcomes in heart failure: evidence and barriers Mode of death in heart failure: findings from the ATLAS trial Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001 Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluation.Population aging and hospitalization for chronic disease in Germany The validity of a diagnosis of heart failure in a hospital discharge register.Conivaptan: a selective vasopressin antagonist for the treatment of heart failure.Innovative telemonitoring system for cardiology: from science to routine operation.Management of end stage heart failure Nebivolol for heart failure in the elderly.Carvedilol in the treatment of elderly patients with chronic heart failure.Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis.Prevalence and inter-relationship of different Doppler measures of dyssynchrony in patients with heart failure and prolonged QRS: a report from CARE-HF Modern approach to the treatment of decompensated heart failure.Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure.Prognostic Implication of QRS Variability during Hospitalization in Patients with Acute Decompensated Heart Failure.Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter?How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey.Telemonitoring for heart failure: the only feasible option for good universal care?Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: the Rotterdam Study.An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study.

P2860

Q24200550-0F1BA9CC-DCA0-4B23-ADD3-D3CFBA48DD86 Q24200713-1D145A8F-2EEB-4B50-855D-3C7396CF0B4A Q24244229-B445C3AA-655B-4DE7-9452-4F6B5F16C0E8 Q24245410-C3E4972F-8EF5-4590-B6FC-79F6127935B3 Q30911176-79D2D591-B2C8-4C0F-AD28-CEC984697D50 Q31064781-A066F996-77B4-4432-B93B-2FB378D5E686 Q33194802-158CC8E0-F3F9-4254-A623-50304F6A48C2 Q33713403-E5F49EF3-8CCC-48C7-A239-ECB78B888426 Q33846333-DFFB3A16-4656-4228-BD12-3C71ADB99CA9 Q33956674-877DE2AE-2281-433B-909F-B631F98C18F9 Q34481280-0336D276-0FF8-4ECF-8A89-09D073AD840A Q35073703-89BB5110-61C7-4670-89D2-922ED913C8F7 Q35404932-3C6C2596-949D-4ADE-8B4F-9FACF806334B Q35521753-BB9C1CF6-953F-4B23-8E6F-07210318BEC9 Q35549766-08FBC282-CEC3-4D71-B4CD-D0B71A1040E2 Q35572277-592ADDE0-57A5-4A03-A37F-039DFF03B28C Q35578969-0C2C0AFE-3E34-450C-A91A-0CCB9D434C19 Q35580685-C4673AF2-B1B1-465C-974A-32413FAA8A38 Q35581168-B3A305E1-8745-4977-AB9D-D8A35693C16D Q35706799-E479F80B-FEE6-4F29-8FE3-6A8B6F19690B Q35836957-098F4698-5D4F-4B58-8187-AED158D3F972 Q35857365-82348273-D0B9-4288-B947-A1EEB8F88AEC Q36139616-CB21F496-61FA-4981-9551-3E3EA947004C Q36351998-16E53D8C-F2DA-4399-8487-2F580020F505 Q36784112-0019A3BB-D5B2-4505-8F15-D0086B31F369 Q36792185-25E59A09-9095-451D-96D6-264A2F352894 Q36815960-F7022255-9022-4301-BA4B-4AC453B1E6C9 Q36892905-902E2E24-AFBC-4EA1-95A2-8072D8627CF7 Q37044831-EEE85C13-5536-4C67-973B-3448D8064880 Q37072870-6B731399-294D-476E-A53D-37C8616624F0 Q37390754-FC172FF3-E48F-4806-A552-0F7AA1DC5F66 Q37404258-92680B63-EA0B-4B18-8A97-66A1FA786554 Q37525962-B4EDB743-70F3-4FCD-B1EE-7C8E7C758165 Q38198026-A529DE09-9117-4597-B0D6-C4F744784A74 Q38576972-C46E2583-24D9-4329-A1BC-3C5FC9F612D3 Q43178435-2800B139-4236-48CB-B55A-C200E4C6E63A Q43269513-CAA86E0F-17DC-431D-B67E-2EE3DA23D8D3 Q43423712-D72909FC-3A21-463B-BF07-D5634F6437A0 Q43711828-F60EF06E-1982-4365-92D5-AF8B83DCCC85 Q44147222-107AE4D1-D1C2-45A3-8B0C-1578C9A5993B

P2860

Is the prognosis of heart failure improving?

http://www.wikidata.org/entity/Q43735732

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Is the prognosis of heart failure improving?

@en

Is the prognosis of heart failure improving?

@nl

type

label

Is the prognosis of heart failure improving?

@en

Is the prognosis of heart failure improving?

@nl

prefLabel

Is the prognosis of heart failure improving?

@en

Is the prognosis of heart failure improving?

@nl

P1433

Q43735732-FCDFAF45-F05F-4350-9D89-315B16EBB812

P1476

Q43735732-15A9E0C6-BB5C-44EE-B017-85D02174AB16

P2093

Q43735732-272516A7-5FCB-4CE2-AB60-568DEEC6459A

Q43735732-579D04D0-986E-4FA7-846F-6036506C40A5

Q43735732-57A343CA-DF28-4F15-A6AF-BD5914DE5A5E

Q43735732-EB3BC603-6C15-4A3E-92A8-681FE717B9C1

P2860

Q43735732-099D81CA-67FB-406F-9D90-E2A02A9BAD00

Q43735732-0F55E1D2-1F1E-4068-AB39-126A548DEA97

Q43735732-2AA83706-0E37-4E2C-BB3D-BE288CC3FD95

Q43735732-2B4BD805-4870-4183-A31B-128828A674E4

Q43735732-461A6EF6-EE8C-4BEB-9AB5-E11817328FF3

Q43735732-5BCACCE3-AA57-4F30-B715-0D8ACDBE91C5

Q43735732-786DF458-891A-4759-9370-6797700834F1

Q43735732-903EAD93-9649-45AA-9C20-78EAE8FEDFE1

Q43735732-957CE869-127A-4A30-9F62-2B8287E4365C

Q43735732-C04BB012-C4D1-4AB4-8E3C-5C2ACB8829E3

P304

Q43735732-D81577CE-B3AF-4B97-A99F-9E4BF2C7AAB8

P31

Q43735732-65ABFD3D-545D-47A4-9B2A-03FEFF2E1D85

P356

Q43735732-FDAC985D-AC42-47D1-8524-1321102E5720

P433

Q43735732-0FCEC89A-9411-46B4-9CD2-9095E962D147

P478

Q43735732-BEC22AF3-020A-416D-AD7D-85106479F03E

P577

Q43735732-40B73BC8-B227-4F32-B61C-3684EE4627CE

P698

Q43735732-B8F60BA8-8D72-423F-B2D7-8FA5682284BE

P921

Q43735732-63573FA9-31D2-4AAF-9D9C-70475D506021

P356

S1388-9842(99)00032-X

P1433

European Journal of Heart Failure

P1476

Is the prognosis of heart failure improving?

@en

P2093

A Boddy

http://www.w3.org/2001/XMLSchema#string

A Khand

http://www.w3.org/2001/XMLSchema#string

I Gemmell

http://www.w3.org/2001/XMLSchema#string

J G Cleland

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.

Changing patterns of investigation and treatment of cardiac failure in hospital

Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure.

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

P304

229-241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1388-9842(99)00032-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10935669

http://www.w3.org/2001/XMLSchema#string

P921